Vnitr Lek 2020, 66(8):507-511 | DOI: 10.36290/vnl.2020.148

Age‑related myocardial remodeling: myth or reality?

Radek Pudil
1 . interní kardiongiologická klinika LF UK a FN Hradec Králové

Age-related myocardial remodeling is a long-term process that involves a wide range of pathogenetic mechanisms. The result is structural and functional changes of the myocardium, which lead to a change in the functional myocardium itself (changes in the geometry of the heart compartments, myocardial contractility, myocardial reserves). These changes can lead to the development of heart failure, reduce the quality of life and thus increase the morbidity and mortality of patients. It is a process that can be negatively affected by risk factors for cardiovascular disease, many comorbidities, on the contrary, this process can be significantly positively influenced by lifestyle changes, early detection of risk factors and consistent treatment of all comorbidities.

Keywords: aging, myocardial remodeling, senescence, heart failure.

Published: December 15, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudil R. Age‑related myocardial remodeling: myth or reality? Vnitr Lek. 2020;66(8):507-511. doi: 10.36290/vnl.2020.148.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Vartiainen E, Sans S, Pasterkamp G, Hughes M, Costanzo S, Donati MB, Jousilahti P, Linneberg A, Palosaari T, de Gaetano G, Bobak M, den Ruijter HM, Jorgensen T, Soderberg S, Kuulasmaa K, Zeller T, Iacoviello L, Salomaa V, Schnabel RB, BiomarCa REC. Sex‑Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium. JACC Heart Fail. 2019; 7(3): 204-213. Go to original source... Go to PubMed...
    2. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2): 194-202. Go to original source... Go to PubMed...
    3. Cheng S, Fernandes VR, Bluemke DA, McClelland RL, Kronmal RA, Lima JA. Age‑related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi‑Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2009; (3): 191-198. Go to original source... Go to PubMed...
    4. Fiechter M, Fuchs TA, Gebhard C, Stehli J, Klaeser B, Stahli BE, Manka R, Manes C, Tanner FC, Gaemperli O, Kaufmann PA. Age‑related normal structural and functional ventricular values in cardiac function assessed by magnetic resonance. BMC Med Imaging. 2013; 13:6. Go to original source... Go to PubMed...
    5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez‑Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129-2200. Go to original source... Go to PubMed...
    6. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD, Houston T, Oslo N, Phoenix A, Nashville T, Hamilton OC, Uppsala S, Ghent, Liege B, Cleveland O, Novara I, Rochester M, Bucharest R, St. Louis M. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17(12): 1321-1360. Go to original source... Go to PubMed...
    7. Evin M, Redheuil A, Soulat G, Perdrix L, Ashrafpoor G, Giron A, Lamy J, Defrance C, Roux C, Hatem SN, Diebold B, Mousseaux E, Kachenoura N. Left atrial aging: a cardiac magnetic resonance feature‑tracking study. Am J Physiol Heart Circ Physiol. 2016; 310(5): H542-549. Go to original source... Go to PubMed...
    8. Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015; 25(6): 475-484. Go to original source... Go to PubMed...
    9. Wehrum T, Lodemann T, Hagenlocher P, Stuplich J, Ngo BTT, Grundmann S, Hennemuth A, Hennig J, Harloff A. Age‑related changes of right atrial morphology and inflow pattern assessed using 4D flow cardiovascular magnetic resonance: results of a population‑based study. J Cardiovasc Magn Reson. 2018; 20(1): 38. Go to original source... Go to PubMed...
    10. Merz AA, Cheng S. Sex differences in cardiovascular ageing. Heart. 2016; 102(11): 825-831. Go to original source... Go to PubMed...
    11. Christou DD, Seals Dr. Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate. J Appl Physiol (1985). 2008; 105(1): 24-29. Go to original source... Go to PubMed...
    12. Wolsk E, Bakkestrom R, Thomsen JH, Balling L, Andersen MJ, Dahl JS, Hassager C, Moller JE, Gustafsson F. The Influence of Age on Hemodynamic Parameters During Rest and Exercise in Healthy Individuals. JACC Heart Fail. 2017; 5(5): 337-346. Go to original source... Go to PubMed...
    13. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerquin‑Kern JL, Lechene CP, Lee RT. Mammalian heart renewal by pre‑existing cardiomyocytes. Nature. 2013 Jan; 493(7432): 433-436. Go to original source... Go to PubMed...
    14. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe‑Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324(5923): 98-102. Go to original source... Go to PubMed...
    15. Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, Sjostrom SL, Szewczykowska M, Jackowska T, Dos Remedios C, Malm T, Andra M, Jashari R, Nyengaard JR, Possnert G, Jovinge S, Druid H, Frisen J. Dynamics of Cell Generation and Turnover in the Human Heart. Cell. 2015; 161(7): 1566-1575. Go to original source... Go to PubMed...
    16. Li H, Hastings MH, Rhee J, Trager LE, Roh JD, Rosenzweig A. Targeting Age‑Related Pathways in Heart Failure. Circ Res. 2020; 126(4): 533-551. Go to original source... Go to PubMed...
    17. Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, Spinale FG. Age‑dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res. 2005; 66(2): 410-419. Go to original source... Go to PubMed...
    18. Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2020 Jun 10. Go to original source... Go to PubMed...
    19. Gonzalez‑Lopez E, Gallego‑Delgado M, Guzzo‑Merello G, de Haro‑Del Moral FJ, Cobo‑Marcos M, Robles C, Bornstein B, Salas C, Lara‑Pezzi E, Alonso‑Pulpon L, Garcia‑Pavia P. Wild‑type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015; 36(38): 2585-2594. Go to original source... Go to PubMed...
    20. Vaclavik J. Blood vessel ageing and vascular memory. Vnitr Lek. 2020; 66(2): 104-110. Go to original source...
    21. Messerli FH, Rimoldi SF, Bangalore S. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC Heart Fail. 2017; 5(8): 543-551. Go to original source... Go to PubMed...
    22. López‑Sainz A dH‑DMJ, Dominguez F, Restrepo‑Cordoba A, Amor‑Salamanca A, Hernandez‑Hernandez A, Ruiz‑Guerrero L, Krsnik I, Cobo‑Marcos M. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders. Amyloid. 2019; 26: 156-136. Go to original source... Go to PubMed...
    23. Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(6): 804-813. Go to original source... Go to PubMed...
    24. Tousoulis D, Oikonomou E, Siasos G, Stefanadis C. Diabetes Mellitus and Heart Failure. Eur Cardiol. 2014; 9(1): 37-42. Go to original source... Go to PubMed...
    25. Seals DR, Brunt VE, Rossman MJ. Keynote lecture: strategies for optimal cardiovascular aging. Am J Physiol Heart Circ Physiol. 2018; 315(2): H183-H188. Go to original source... Go to PubMed...
    26. Seals DR, Brunt VE, Rossman MJ. Keynote lecture: strategies for optimal cardiovascular aging. 2018; 315(2): H183-H188.
    27. Woo JS, Derleth C, Stratton JR, Levy WC. The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol. 2006; 47(5): 1049-1057. Go to original source... Go to PubMed...
    28. Roh J, Rhee J, Chaudhari V, Rosenzweig A. The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms. Circ Res. 2016; 118(2): 279-295. Go to original source... Go to PubMed...
    29. Fujimoto N, Prasad A, Hastings JL, Arbab‑Zadeh A, Bhella PS, Shibata S, Palmer D, Levine BD. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation. 2010; 122(18): 1797-1805. Go to original source... Go to PubMed...
    30. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Poss J, Bauersachs J, Thum T, Pfreundschuh M, Muller P, Haendeler J, Bohm M, Laufs U. Effects of physical exercise on myocardial telomere‑regulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol. 2008; 52(6): 470-482. Go to original source... Go to PubMed...
    31. Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation. 2009; 120(24): 2438-2447. Go to original source... Go to PubMed...
    32. Liao PH, Hsieh DJ, Kuo CH, Day CH, Shen CY, Lai CH, Chen RJ, Padma VV, Kuo WW, Huang CY. Moderate exercise training attenuates aging‑induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts. Oncotarget. 2015; 6(34): 35383-35394. Go to original source... Go to PubMed...
    33. Vujic A, Lerchenmuller C, Wu TD, Guillermier C, Rabolli CP, Gonzalez E, Senyo SE, Liu X, Guerquin‑Kern JL, Steinhauser ML, Lee RT, Rosenzweig A. Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat Commun. 2018; 9(1): 1659. Go to original source... Go to PubMed...
    34. Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, Ference TB, Guo Q, Laufs U, Ruff CT, Cupido A, Hovingh GK, Danesh J, Holmes MV, Smith GD, Ray KK, Nicholls SJ, Sabatine MS. Association of Genetic Variants Related to Combined Exposure to Lower Low‑Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. JAMA. 2019; 322: 1381-1391. Go to original source... Go to PubMed...
    35. Ray KK, Laufs U, Cosentino F, Lobo MD, Landmesser U. The year in cardiology: cardiovascular prevention. Eur Heart J. 2020; 41(11): 1157-1163. Go to original source... Go to PubMed...
    36. Lim GB. Reductions in LDL‑cholesterol and blood‑pressure levels have cumulative benefits. Nat Rev Cardiol. 2019; 16(11): 650. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.